Axion biosystems maestro pro microelectrode array (MEA) system – brand name or equal

Closed Solicitation Posted

Solicitation number
CBER-2026-135659
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Georgia, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Food and Drug Administration's Center for Biologics Evaluation and Research seeks quotation for one Axion BioSystems Maestro Pro Microelectrode Array (MEA) system, brand name or equal, with quotations due September 16, 2026 at 9:00 AM Eastern Time and questions due September 11, 2026 at 9:00 AM Eastern Time. This is an unrestricted commercial acquisition under FAR Part 12 simplified procedures with no small business set-aside, issued as RFQ CBER-2026-135659.

Place of performance is FDA/CBER Building 52/72, Room 3148, Silver Spring, Maryland, with equipment delivery required within 90 calendar days of award. The system must deliver a minimum of 768 simultaneous recording and stimulation channels with a sampling rate of at least 12.5 kHz, impedance measurement capability across 50 ohms to 100 kilohms, real-time electrophysiology analysis, and support for 2D and 3D biological models compatible with 6-well through 96-well MEA plates and 384-well impedance formats. Recording bandwidth must span 0.01 Hz to 5 kHz; stimulation must support up to 1.2 volts and 250 microamps; integrated environmental controls must achieve 37 degrees Celsius, 0-10% CO2, and humidity control.

Deliverables include all hardware, software with minimum two user seats, consumables, onsite installation and calibration within 30 days of delivery, two days of onsite training within 60 days of delivery, computer equipment, and one-year manufacturer's standard warranty. An optional Year 1 preventive maintenance package is available. Award will be made using Lowest-Priced Technically Acceptable methodology with evaluation criteria of Technical Acceptability, Past Performance (Acceptable/Neutral/Unacceptable), and Price, with no tradeoffs permitted. Quoters must submit a Technical Compliance Matrix, pricing spreadsheet, past performance references, and certifications regarding country of origin and trade agreement compliance. Contracting Officer is Michele Jackson; Technical Point of Contact is Dr. Dwi U. Kemaladewi, Ph.D.

Notice text

This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with Federal Acquisition Regulation (FAR) Part 12, as implemented through the Revolutionary FAR Overhaul (RFO) model deviation and applicable Department of Health and Human Services (HHS) class deviations.

This announcement constitutes solicitation. Quotations are being requested, and a separate written solicitation will not be issued.

Solicitation No. CBER-2026-135659 is issued as a Request for Quotation (RFQ) for the purchase of an Axion BioSystems Maestro Pro Microelectrode Array (MEA) System, brand name or equal, together with the required software, consumables, installation, training, warranty, and an option for preventive maintenance.

This acquisition is not set aside for small business concerns and is being competed on an unrestricted basis.

The Government intends to issue a Firm-Fixed-Price purchase order using simplified procedures for commercial products and commercial services under RFO FAR Part 12.

Please refer to the Combined Synopsis-Solicitation  Maestro Pro Microelectrode Array System Document and all the attachments for specfic details about the requirement 

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity